Study participants who had a history of stroke were nearly 60% less likely to meet guideline-recommended secondary prevention goals, new research reveals.
Patient Care Online July 2024
Digital Edition for Patient Care Online for July, 2024
ACC. 24: A structured, systematic approach to lipid-lowering therapy in secondary prevention is needed to ensure targets are met and met swiftly, said researchers.
Bempedoic acid is now the only non-statin therapy indicated for primary CVD prevention, with potential to expand treatment access to millions, said Esperion Therapeutics.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication
2
Reminders for Primary Care Physicians, Patients Improved Annual Lung Cancer Screening Adherence
3
Avexitide Reduced Hypoglycemic Events in Phase 3 Post-Bariatric Hypoglycemia Trial
4